Radiologists who use imaging-related electronic record-keeping could qualify for some of the $19 billion in economic recovery money set aside for electronic health record conversion if they meet the federal government’s definition of “meaningful use” for their records.
Radiologists who use imaging-related electronic record-keeping could qualify for some of the $19 billion in economic recovery money set aside for electronic health record conversion if they meet the federal government's definition of "meaningful use" for their records.
A federal advisory committee to the U.S. Department of Health and Human Services took a first stab June 16 at defining meaningful use as it pertains to EHRs.
"Today we outlined a vision for where we are heading with the concept of meaningful use," said David Blumenthal, chair of the HHS Health Information Technology Policy Committee. "That vision calls for the exchange of information on a wide range of items."
The HIT Policy Committee focused on recommendations from its Meaningful Use Workgroup. A general guide appearing in the preamble of its work noted that meaningful use should ultimately be linked to achieving measurable outcomes in patient engagement, care coordination, and population health.
A meaningful use matrix included several specifics that apply to medical imaging. One is an objective for 2011 governing the exchange of test results among care providers. A second 2011 goal involves a measure calling for reporting of the percentages of patients aged 50 and older who receive annual colorectal cancer screenings and of women over the same age who get annual mammograms. A metric potentially to be applied in 2013 calls for the measurement of inappropriate imaging procedures, such as the use of MRI for acute low back pain.
Agreement on a final definition is months away. Blumenthal emphasized that the committee's work is only advisory and that the Centers for Medicare and Medicaid Services, which is part of HHS, will write the final rules.
The public will have until June 26 to comment on today's recommendations.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.